The India Respiratory Drugs Market growth continues to accelerate as chronic obstructive pulmonary disease emerges as a major public health challenge driven by tobacco smoking, biomass fuel use, occupational dust exposure, and ambient air pollution. With India estimated to have over 50 million COPD patients and the country contributing significantly to global COPD mortality, the demand for...